Athletic apparel company Under Armour (NYSE:UAA) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 11.4% year on year to $1.18 billion. On the other hand, next quarter’s revenue guidance of $1.13 billion was less impressive, coming in 3.4% below analysts’ estimates. Its non-GAAP loss of $0.08 per share was in line with analysts’ consensus estimates.
E-commerce and gaming company Sea (NYSE:SE) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 29.6% year on year to $4.84 billion. Its GAAP profit of $0.65 per share was 7.1% above analysts’ consensus estimates.
Palmer Luckey sold Oculus to Facebook for $2 billion in 2014 and joined an ultra-exclusive group chat for founders who have sold a company for at least $1 billion.
The recent relaxation of tariffs between the U.S. and China has sparked a significant market rally, with tech CEOs and founders reaping substantial benefits.
Alternate site health provider Option Care Health (NASDAQ:OPCH) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 16.3% year on year to $1.33 billion. The company’s full-year revenue guidance of $5.5 billion at the midpoint came in 1.3% above analysts’ estimates. Its non-GAAP profit of $0.40 per share was 20% above analysts’ consensus estimates.
Alzamend Neuro starts Phase 2 trial of AL001 with novel coil tech to test improved lithium delivery in the brain for multiple mental health conditions.
